Cite
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.
MLA
Paoletti, Costanza, et al. “Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor-Positive Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 21, no. 11, June 2015, pp. 2487–98. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-14-1913.
APA
Paoletti, C., Muñiz, M. C., Thomas, D. G., Griffith, K. A., Kidwell, K. M., Tokudome, N., Brown, M. E., Aung, K., Miller, M. C., Blossom, D. L., Schott, A. F., Henry, N. L., Rae, J. M., Connelly, M. C., Chianese, D. A., & Hayes, D. F. (2015). Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(11), 2487–2498. https://doi.org/10.1158/1078-0432.CCR-14-1913
Chicago
Paoletti, Costanza, Maria C Muñiz, Dafydd G Thomas, Kent A Griffith, Kelley M Kidwell, Nahomi Tokudome, Martha E Brown, et al. 2015. “Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor-Positive Breast Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 21 (11): 2487–98. doi:10.1158/1078-0432.CCR-14-1913.